ALINAMIN EX PLUS

Serial Number 87740567
Registration 5810018
700

Registration Progress

Application Filed
Jan 2, 2018
Under Examination
Jun 11, 2019
Approved for Publication
Apr 16, 2019
Published for Opposition
Apr 16, 2019
Registered
Jul 23, 2019

Attorney Assistance

Section 8 (6-Year) Declaration Due (Based on registration date 2019-07-23) (Grace Period Filing)
Due: Jan 23, 2026 Grace Period - 177 days
Original deadline was Jul 23, 2025 (overdue)

Trademark Image

ALINAMIN EX PLUS

Basic Information

Serial Number
87740567
Registration Number
5810018
Filing Date
January 2, 2018
Registration Date
July 23, 2019
Published for Opposition
April 16, 2019
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jul 23, 2019
Registration
Registered
Classes
005

Rights Holder

ALINAMIN PHARMACEUTICAL CO., LTD.

03
Address
8-2, MARUNOUCHI 1-CHOME, CHIYODA-KU
TOKYO 100-0005
JP

Ownership History

Takeda Consumer Healthcare Company Limited

Original Applicant
03
Tokyo 100-0005 JP

Takeda Consumer Healthcare Company Limited

Owner at Publication
03
Tokyo 100-0005 JP

Takeda Consumer Healthcare Company Limited

Original Registrant
03
Tokyo 100-0005 JP

ALINAMIN PHARMACEUTICAL CO., LTD.

New Owner After Registration #1
03
TOKYO JP

Legal Representation

Attorney
Bassam N. Ibrahim

USPTO Deadlines

Next Deadline
In Grace Period
Section 8 (6-Year) Declaration Due (Based on registration date 2019-07-23)
Due Date
July 23, 2025
Grace Period Ends
January 23, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

36 events
Date Code Type Description Documents
Jul 23, 2024 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
May 19, 2021 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Jul 23, 2019 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jun 19, 2019 DP1B I 1(B) BASIS DELETED; PROCEED TO REGISTRATION Loading...
Jun 11, 2019 IUCN S NOTICE OF ALLOWANCE CANCELLED Loading...
Jun 11, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jun 3, 2019 PC.D I PETITION TO DIRECTOR DISMISSED Loading...
May 30, 2019 APET A ASSIGNED TO PETITION STAFF Loading...
Apr 26, 2019 TPAD I TEAS PETITION TO AMEND BASIS RECEIVED Loading...
Apr 16, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 16, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 27, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 12, 2019 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Mar 11, 2019 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 11, 2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 11, 2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 8, 2019 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
Feb 15, 2019 GNS2 O NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Loading...
Feb 15, 2019 GNSI S INQUIRY TO SUSPENSION E-MAILED Loading...
Feb 15, 2019 CNSI R SUSPENSION INQUIRY WRITTEN Loading...
Feb 14, 2019 RCCK S SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Loading...
Aug 8, 2018 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Aug 8, 2018 GNSL S LETTER OF SUSPENSION E-MAILED Loading...
Aug 8, 2018 CNSL R SUSPENSION LETTER WRITTEN Loading...
Jul 18, 2018 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jul 18, 2018 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jul 18, 2018 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Apr 5, 2018 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Apr 5, 2018 GNRT F NON-FINAL ACTION E-MAILED Loading...
Apr 5, 2018 CNRT R NON-FINAL ACTION WRITTEN Loading...
Apr 4, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 30, 2018 AMPX O PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED Loading...
Jan 25, 2018 ALIE A ASSIGNED TO LIE Loading...
Jan 17, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 10, 2018 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED Loading...
Jan 5, 2018 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for human use, namely, for the relief of muscular pain, shoulder stiffness, lumbar pain and eyestrain; vitamin preparations; nutritional additives for medical purposes in the nature of dietary supplements; dietetic beverages, namely, energy drinks adapted for medical purposes; dietary supplement drinks for medical purposes

Classification

International Classes
005